Bezlotoxumab for preventing recurrent Clostridium difficile infection (terminated appraisal) (TA601)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 25 September 2019
Pneumonia (hospital-acquired): antimicrobial prescribing (NG139)Product type:GuidanceProgramme:NICE guidelinePublished date: 16 September 2019
Letermovir for preventing cytomegalovirus disease after a stem cell transplant (TA591)Product type:GuidanceProgramme:Technology appraisal guidancePublished date: 31 July 2019
PneuX for preventing ventilator-associated pneumonia in intensive careStatus:In developmentProgramme:Medical technologies guidanceExpected publication date: 27 March 2020
Clostridium difficile infection: antimicrobial prescribingStatus:In developmentProgramme:NICE guidelineExpected publication date: 30 September 2020
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissuesStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: TBC
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices [ID1440]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC